For up-to-date news regarding Locate Therapeutics, please visit our Linked-In page.
27th Jan 2017.
Nottingham based, Locate Therapeutics (“Locate”) announced today the deepening of a development collaboration with the innovative orthopaedic company, Heraeus Medical GmbH. Full article >
11th Feb 2016.
Locate Therapeutics Ltd ("Locate"), the regenerative medicine development company, and the School of Pharmacy at The University of Nottingham, have been awarded a grant from Innovate UK. Full article >
5th Jan 2015.
Locate Therapeutics Ltd ("Locate"), the regenerative medicine development company, today announced the appointment of Dr Ian Wilding as Chairman of the Board of Directors. Full article >
9th Dec 2014.
Wehrheim, December 2014 – Heraeus Medical GmbH announced today an agreement with Locate Therapeutics to license the intellectual property surrounding the use of TAOS® in orthopaedic applications and the inception of the first development program in this field. Full article >
4th Dec 2014.
Locate Therapeutics Ltd, a Nottingham based specialist regenerative medicine company has been awarded a grant from the Healthcare and Bioscience iNetFull article >
28th Nov 2014.
ocate Therapeutics Ltd ("Locate"), the regenerative medicine and devices company, has received notification that it will be granted a new patent covering its TAOS™ (Tailored Orchestrated Signalling matrix) technology across Europe (European Patent No. 2 125 048). Full article >
9th May 2014, Hanau, Germany.
Precious metal and technology Group, Heraeus Holding (Heraeus), announced today the completion of an equity investment in Nottingham based regenerative medicine platform company, Locate Therapeutics (Locate). Full article >
For further information please email email@example.com or call +44 (0)115 784 0041.